Stanford Coulter Award: Februrary 24th Deadline Approaching
Deadline: February 24, 2020 (before MIDNIGHT, PST) Finalists selected in late-March. Finalist presentations in mid-April.
Program: The Wallace H. Coulter Foundation provides funding to support collaborative translational research projects that involve co-principal investigators from the Department of Bioengineering and a clinical department in the School of Medicine. The goal of this program is to encourage research that addresses unmet clinical needs and leads to improvements in health care and to commercial products. Examples of desirable outcomes include inventions, patents, improved diagnosis and treatment of disease, commercial products, licenses, commercial partnerships and startup companies.
Award Amount: Up to $100,000 direct cost for one year.
Eligibility Criteria: Each proposal must have at least two co-principal investigators (please contact program if assistance with finding collaborators is needed - we may be able to help)
One with a full, joint, or courtesy UTL, MCL, and NTL-Research faculty appointment in the Department of Bioengineering at Stanford
And at least one with a full, joint, or courtesy UTL, MCL, NTL-Research or Clinician Educator faculty appointment in a clinical department in the School of Medicine
Other team members (grad students, postdocs, research staff, etc.) may be listed on the proposal
Intellectual property of core technology must be owned by Stanford (not under an option or license to any entity)
A PDRF is not due at the time of proposal submission, however, in the event the proposal advances to the finalist screening stage, initation of a PDRF will be required prior to the finalist presentations in Mid-April, specific date/time to be determined by February.
Funding will not be dispersed without clearance of any applicable APLAC, IRB or IRB exemption requirements
For more information, please visit out Coulter Award page.